11Oct
05Oct
Angel Insights Webinar Series
Upcoming Angel Capital Association webinar featuring Ziad Moukheiber, CEO of Boston Harbor Angels. Pre-Money Valuations: Do They Matter as Much as Many Angels Think? Read more >>
04Oct
September VC Funding Update: 54 Startups Raise More Than a Billion Dollars
The summer slump wore off in September with over 50 Boston startups raising north of a billion dollars in venture funding, including Platelet BioGenesis. Read more >>
04Oct
Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual Meeting
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, announced the presentation of three abstracts at the American College of Rheumatology (“ACR”) 2019 Annual Meeting being held November 8-13, 2019 in Atlanta, Georgia. Read more >>
03Oct
Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening
Xylyx Bio, a pioneer in tissue-specific extracellular matrix biomaterials, today announced the development of substrates for anti-fibrotic drug discovery as the next stage of its pipeline of pre-clinical cell culture products. Read more >>
03Oct
MarTech Interview with Lynn Browne and Mollie Kehoe, Co-Founders at BrandVerge
How did you get into technology? What inspired you to start BrandVerge? Lynn: I think what really inspired us to do both, is personal frustration in our professional careers. Mollie: When we sat down and really thought about it, there’s so many technologies that have disrupted and helped make our personal lives easier. Read more >>
03Oct
One of Louisville’s largest manufacturing firms acquires Arizona company
This deal comes after Rev-A-Shelf acquired CompoKeeper, a brand of kitchen composters, from 1908 Brands of Boulder, Colo in 2018. Read more >>
03Oct
New technology may aid emergency preparedness
The Department of Health and Human Services (HHS) has earmarked funds to aid the development of new technology that could bolster emergency preparedness by producing platelets outside the human body. If the two-year, $4.9 million agreement between HHS Biomedical Advanced Research and Development Authority (BARDA) and Platelet BioGenesis, Inc. (PBG) of Cambridge, Mass., produces the desired results, the technology would improve emergency preparedness by making additional blood products available to save lives during a radiological or nuclear emergency. Read more...
03Oct
Emovi Announces Results of Clinical Trial to Manage Knee Osteoarthritis with KneeKGTM
Today, Emovi, Inc. announces positive results from a randomized, controlled trial involving KneeKG™, Emovi’s flagship medical device and the first device that enables healthcare professionals to accurately assess patients’ knees in 3D while the patient is moving and weight-bearing. Read more >>
02Oct